BharatNotes What is Cartagena Protocol?
The Cartagena Protocol on Biosafety is a legally binding international treaty under the Convention on Biological Diversity (CBD) that regulates the transboundary movement, transit, handling and use of Living Modified Organisms (LMOs) resulting from modern biotechnology. Adopted on 29 January 2000 in Montreal and entered into force on 11 September 2003, it was the first global agreement to specifically address the biosafety risks of genetically engineered organisms. Its core objective is to protect biological diversity and human health while still permitting safe biotechnology trade.
An LMO under the Protocol is any living organism with a novel combination of genetic material obtained through modern biotechnology (e.g., GM seeds capable of reproducing). The treaty famously enshrines the precautionary approach (echoing Rio Principle 15), permitting importing countries to refuse or restrict an LMO even where full scientific certainty of harm is lacking.
Key Features
| Feature | What it does |
|---|---|
| Advance Informed Agreement (AIA) | Exporters must notify, and obtain consent from, the importing country before the first shipment of an LMO meant for intentional introduction into the environment |
| Precautionary approach | Allows import refusal despite scientific uncertainty about adverse effects |
| Biosafety Clearing-House (BCH) | Online information-exchange platform to help Parties share LMO data and meet obligations |
| Risk assessment & management | Science-based evaluation of LMO risks before release |
| Documentation | LMOs in shipments must be identified ("may contain" / "contains" LMOs) |
The Protocol's scope is widest for LMOs meant for intentional introduction into the environment; LMOs meant for direct use as food, feed or processing (FFPs) follow a lighter information-sharing regime, and LMOs for contained use or in transit are largely exempt from the AIA procedure.
Current Status
The Protocol has 173 Parties (as of the CBD Biosafety Clearing-House list, August 2024), including the European Union. India ratified it in January 2003 and is therefore a Party. Notably, the United States is not a Party, as it is not a Party to the parent CBD. The Protocol is supplemented by the Nagoya–Kuala Lumpur Supplementary Protocol on Liability and Redress (adopted 2010; entered into force on 5 March 2018), which India ratified in 2014.
In India, biosafety is governed chiefly by the "Rules, 1989" (Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms / Genetically Engineered Organisms or Cells) under the Environment (Protection) Act, 1986, with the Genetic Engineering Appraisal Committee (GEAC) under the MoEFCC as the apex approval body.
UPSC Angle
For Prelims, focus on the parent treaty (CBD), the subject matter (LMOs, not access/benefit-sharing), the year, and crucial distinctions: do not confuse it with the Nagoya Protocol (ABS) or the marine Cartagena Convention (Caribbean pollution). For Mains (GS3), it anchors discussion of biotechnology regulation, the precautionary principle, and India's contested GM-crop decisions (Bt brinjal moratorium, GM mustard). It is a foundational concept underpinning questions on international environmental conventions and GMO governance.
